Australia markets close in 2 hours 33 minutes

iBio, Inc. (IBIO)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.7200-0.1800 (-9.47%)
At close: 04:00PM EDT
1.7200 0.00 (0.00%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 14.81M
Enterprise value 28.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)111.58
Price/book (mrq)1.61
Enterprise value/revenue 569.85
Enterprise value/EBITDA -1.47

Trading information

Stock price history

Beta (5Y monthly) -3.52
52-week change 3-92.04%
S&P500 52-week change 321.08%
52-week high 322.8000
52-week low 31.0200
50-day moving average 31.6422
200-day moving average 34.3277

Share statistics

Avg vol (3-month) 33.9M
Avg vol (10-day) 3193.34k
Shares outstanding 58.61M
Implied shares outstanding 69.51M
Float 82.65M
% held by insiders 10.18%
% held by institutions 126.90%
Shares short (15 Apr 2024) 4184.45k
Short ratio (15 Apr 2024) 40.02
Short % of float (15 Apr 2024) 42.17%
Short % of shares outstanding (15 Apr 2024) 42.17%
Shares short (prior month 15 Mar 2024) 459.32k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 June 2018
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 329 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-41,466.00%

Management effectiveness

Return on assets (ttm)-30.20%
Return on equity (ttm)-148.27%

Income statement

Revenue (ttm)50k
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -19.83M
Net income avi to common (ttm)-20.77M
Diluted EPS (ttm)-13.8100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.79M
Total cash per share (mrq)0.8
Total debt (mrq)17.27M
Total debt/equity (mrq)187.81%
Current ratio (mrq)0.91
Book value per share (mrq)2.84

Cash flow statement

Operating cash flow (ttm)-18.89M
Levered free cash flow (ttm)-99.12k